These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 17714116)

  • 21. Sleep impairment in patients with painful diabetic peripheral neuropathy.
    Zelman DC; Brandenburg NA; Gore M
    Clin J Pain; 2006 Oct; 22(8):681-5. PubMed ID: 16988563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quality of life and its relationship to the degree of illness acceptance in patients with diabetes and peripheral diabetic neuropathy.
    Lewko J; Polityńska B; Kochanowicz J; Zarzycki W; Okruszko A; Sierakowska M; Jankowiak B; Górska M; Krajewska-Kułak E; Kowalczuk K
    Adv Med Sci; 2007; 52 Suppl 1():144-6. PubMed ID: 18229653
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cross-national burden of painful diabetic peripheral neuropathy in Asia, Latin America, and the Middle East.
    Hoffman DL; Sadosky A; Alvir J
    Pain Pract; 2009; 9(1):35-42. PubMed ID: 19019046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of acetyl-L-carnitine in the treatment of diabetic peripheral neuropathy.
    Evans JD; Jacobs TF; Evans EW
    Ann Pharmacother; 2008 Nov; 42(11):1686-91. PubMed ID: 18940920
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetes.
    Davies M; Brophy S; Williams R; Taylor A
    Diabetes Care; 2006 Jul; 29(7):1518-22. PubMed ID: 16801572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diabetic peripheral neuropathic pain: case studies.
    Belgrade MJ; Cole BE; McCarberg BH; McLean MJ
    Mayo Clin Proc; 2006 Apr; 81(4 Suppl):S26-32. PubMed ID: 16608050
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Practice guidelines for neuropathic pain management].
    Guevara-López U; Covarrubias-Gómez A; García-Ramos G; Hernández-Jiménez S;
    Rev Invest Clin; 2006; 58(2):126-38. PubMed ID: 16827265
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Review of the symptomatic treatment of diabetic neuropathy.
    Wright JM
    Pharmacotherapy; 1994; 14(6):689-97. PubMed ID: 7885972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Opioid utilization and health-care costs among patients with diabetic peripheral neuropathic pain treated with duloxetine vs. other therapies.
    Wu N; Chen SY; Hallett LA; Boulanger L; Fraser KA; Patel CK; Zhao Y
    Pain Pract; 2011; 11(1):48-56. PubMed ID: 20602718
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A longitudinal assessment of painful diabetic peripheral neuropathy on health status, productivity, and health care utilization and cost.
    daCosta DiBonaventura M; Cappelleri JC; Joshi AV
    Pain Med; 2011 Jan; 12(1):118-26. PubMed ID: 21087406
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence and risk factors of neuropathic pain in survivors of myocardial infarction with pre-diabetes and diabetes. The KORA Myocardial Infarction Registry.
    Ziegler D; Rathmann W; Meisinger C; Dickhaus T; Mielck A;
    Eur J Pain; 2009 Jul; 13(6):582-7. PubMed ID: 18782673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diabetic Peripheral Neuropathic Pain From the Perspective of Turkish Patients: A Qualitative Study.
    Gok Metin Z; Arslan IE
    J Transcult Nurs; 2018 Nov; 29(6):514-522. PubMed ID: 29338623
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect and safety of spinal cord stimulation for treatment of chronic pain caused by diabetic neuropathy.
    de Vos CC; Rajan V; Steenbergen W; van der Aa HE; Buschman HP
    J Diabetes Complications; 2009; 23(1):40-5. PubMed ID: 18413161
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A clinical profile of a cohort of patients referred to an anesthesiology-based pediatric chronic pain medicine program.
    Vetter TR
    Anesth Analg; 2008 Mar; 106(3):786-94, table of contents. PubMed ID: 18292420
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Understanding the impact of painful diabetic neuropathy.
    Quattrini C; Tesfaye S
    Diabetes Metab Res Rev; 2003; 19 Suppl 1():S2-8. PubMed ID: 12577252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Duloxetine in the management of diabetic peripheral neuropathic pain.
    Ormseth MJ; Scholz BA; Boomershine CS
    Patient Prefer Adherence; 2011; 5():343-56. PubMed ID: 21845034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiepileptic drugs in treatment of pain caused by diabetic neuropathy.
    Gutierrez-Alvarez AM; Beltrán-Rodríguez J; Moreno CB
    J Pain Symptom Manage; 2007 Aug; 34(2):201-8. PubMed ID: 17572057
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders.
    Weaver MR; Conover CJ; Proescholdbell RJ; Arno PS; Ang A; Uldall KK; Ettner SL
    J Ment Health Policy Econ; 2009 Mar; 12(1):33-46. PubMed ID: 19346565
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The epidemiology of cancer pain.
    Goudas LC; Bloch R; Gialeli-Goudas M; Lau J; Carr DB
    Cancer Invest; 2005; 23(2):182-90. PubMed ID: 15813511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.